Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (30)

2024

  1. Light deficiency in Apoe−/−mice increases atheroma plaque size and vulnerability by modulating local immunity

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 4

  2. Treatment with 1.25% cholesterol enriched diet produces severe fatty liver disease characterized by advanced fibrosis and inflammation and impaired autophagy in mice

    Journal of Nutritional Biochemistry, Vol. 134

2023

  1. CCL17 and CCL22 chemokines are upregulated in human obesity and play a role in vascular dysfunction

    Frontiers in Endocrinology, Vol. 14

2022

  1. Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone Peptide-Derived G Protein Coupled Receptor Agonists

    Nutrients, Vol. 14, Núm. 18

  2. Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptor

    Clinica e Investigacion en Arteriosclerosis

2021

  1. Dissecting abdominal aortic aneurysm is aggravated by genetic inactivation of light (Tnfsf14)

    Biomedicines, Vol. 9, Núm. 11

  2. Overexpression of glucose 6 phosphate dehydrogenase preserves mouse pancreatic beta cells function until late in life

    Free Radical Biology and Medicine, Vol. 164, pp. 149-153

  3. Postprandial triglyceridaemia is modulated by insulin resistance but not by grade of obesity in abdominal and morbid obese subjects

    International Journal of Clinical Practice, Vol. 75, Núm. 4

  4. Therapies for the treatment of cardiovascular disease associated with type 2 diabetes and dyslipidemia

    International Journal of Molecular Sciences, Vol. 22, Núm. 2, pp. 1-27

2020

  1. Dapagliflozin does not modulate atherosclerosis in mice with insulin resistance

    International Journal of Molecular Sciences, Vol. 21, Núm. 23, pp. 1-18

  2. Impact of cholesterol metabolism in immune cell function and atherosclerosis

    Nutrients, Vol. 12, Núm. 7, pp. 1-19

  3. Srebf2 locus overexpression reduces body weight, total cholesterol and glucose levels in mice fed with two different diets

    Nutrients, Vol. 12, Núm. 10, pp. 1-15

  4. TET2-Loss-of-Function-Driven Clonal Hematopoiesis Exacerbates Experimental Insulin Resistance in Aging and Obesity

    Cell Reports, Vol. 33, Núm. 4

2019

  1. Aging in Rodents

    Encyclopedia of Biomedical Gerontology: Volume 1-3 (Elsevier), pp. V1-73-V1-87

  2. Aging in rodents

    Encyclopedia of Biomedical Gerontology (Elsevier), pp. 73-87

  3. Anti-inflammatory Therapies for Cardiovascular Disease: Signaling Pathways and Mechanisms

    Revista Espanola de Cardiologia, Vol. 72, Núm. 9, pp. 767-773

  4. Changes in CDKN2A/2B expression associate with T-cell phenotype modulation in atherosclerosis and type 2 diabetes mellitus

    Translational Research, Vol. 203, pp. 31-48

  5. Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis

    Diabetologia, Vol. 62, Núm. 11, pp. 2143-2157

  6. Novel immune features of the systemic inflammation associated with primary hypercholesterolemia: Changes in cytokine/chemokine profile, increased platelet and leukocyte activation

    Journal of Clinical Medicine, Vol. 8, Núm. 1

  7. SGLT-2 (Sodium-Glucose Cotransporter 2) Inhibition Reduces Ang II (Angiotensin II)-Induced Dissecting Abdominal Aortic Aneurysm in ApoE (Apolipoprotein E) Knockout Mice

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 39, Núm. 8, pp. 1614-1628